‘93/’94 Year-End Review and Outlook : Industry Outlook : Continuing low-grade growth in the national economy, coupled with hopes for stability--if not expansion--in California, is the backdrop for the year in business. Here is an assessment of key industries’ prospects.
- Share via
This report was compiled by Times staff writer Donna K.H. Walters
PHARMACEUTICALS: The industry will muster forces against any health care reforms that would limit new drug prices. Meantime, a host of new genetically engineered drugs will enter the federal review pipeline. Blockbuster products could revive Wall Street’s interest.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
